1. Home
  2. CCS vs HROW Comparison

CCS vs HROW Comparison

Compare CCS & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$61.39

Market Cap

2.0B

ML Signal

HOLD

HROW

Harrow Inc.

HOLD

Current Price

$33.99

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
HROW
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
CCS
HROW
Price
$61.39
$33.99
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$64.80
$69.86
AVG Volume (30 Days)
227.5K
453.1K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
71.43
EPS
2.09
N/A
Revenue
$4,117,816,000.00
N/A
Revenue This Year
N/A
$31.62
Revenue Next Year
$10.84
$50.77
P/E Ratio
$28.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.28
$28.54
52 Week High
$76.00
$54.98

Technical Indicators

Market Signals
Indicator
CCS
HROW
Relative Strength Index (RSI) 34.67 31.95
Support Level $60.46 $32.74
Resistance Level $61.13 $36.37
Average True Range (ATR) 1.89 1.58
MACD -0.85 -0.43
Stochastic Oscillator 14.61 2.21

Price Performance

Historical Comparison
CCS
HROW

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: